Patents by Inventor Henry V. Secor

Henry V. Secor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extraction process using a novel organic acid as a liquid ion exchanger
    Patent number: 5230802
    Abstract: This invention provides novel organic acids which exhibit utility as liquid ion exchanges suitable for use in an invention solvent extraction process. Illustrative of an invention organic acid is a compound corresponding to the formula: ##STR1## where each of R.sub.1 and R.sub.2 is a C.sub.3 -C.sub.16 branched alkyl group.
    Type: Grant
    Filed: June 24, 1992
    Date of Patent: July 27, 1993
    Assignees: Philip Morris Incorporated, Philip Morris Products Inc.
    Inventors: Robert N. Ferguson, Charles R. Howe, Henry V. Secor, Jeffrey I. Seeman
  • Nicotine analogs
    Patent number: 5138062
    Abstract: This invention provides a class of nicotine analogs which as therapeutic agents exhibit tranquilizing effects in mammals.Illustrative of an invention nicotine analog is 3-[N-methyl-N-(3-aminopropyl)]aminomethylpyridine ##STR1## the nicotine analogs can exist in the form of acid addition salts.
    Type: Grant
    Filed: November 28, 1990
    Date of Patent: August 11, 1992
    Assignees: Philip Morris Incorporated, Philip Morris Products Inc.
    Inventors: Thomas S. Osdene, Henry V. Secor, Jeffrey I. Seeman
  • Smoking compositions containing a heteroaromatic flavorant-release additive
    Patent number: 5080719
    Abstract: This invention privdes novel heteroaromatic compounds, and smoking compositions which contain an invention heteroaromatic compound as a flavorant-release additive as illustrated by the following additive structure: ##STR1## Under typical cigarette smoking conditions, 2-isopropylpyrazine and acetophenone are released as pyrolysis products, and enhance the flavor and aroma of the mainstream and sidestream smoke.
    Type: Grant
    Filed: September 24, 1987
    Date of Patent: January 14, 1992
    Assignee: Philip Morris Incorporated
    Inventors: Yoram Houminer, Henry V. Secor, Jeffrey I. Seeman
  • Nicotine analogs
    Patent number: 5015741
    Abstract: This invention provides a novel class of nicotine analogs which as therapeutic agents exhibit tranquilizing effects in mammals.Illustrative of invention nicotine analogs are 1-(3-dimethylaminopropyl)-2-(3-pyridyl)pyrrolidine: ##STR1## and (R,S)-6-(N,N-dimethyl-3-aminopropyl)nicotine: ##STR2## The nicotine analogs can exist in the form of acid addition salts.
    Type: Grant
    Filed: October 3, 1989
    Date of Patent: May 14, 1991
    Assignee: Philip Morris Incorporated
    Inventors: Thomas S. Osdene, Henry V. Secor, Jeffrey I. Seeman
  • Process for preparing 2-alkyl nicotinoids
    Patent number: 4220781
    Abstract: The invention relates to 2-alkyl nicotinoids and improved methods for producing them.
    Type: Grant
    Filed: December 21, 1978
    Date of Patent: September 2, 1980
    Assignee: Philip Morris, Inc.
    Inventors: Edward B. Sanders, Henry V. Secor, Jeffrey I. Seeman
  • Method of producing .gamma.-amino alcohols
    Patent number: 4216329
    Abstract: A process for the production of .gamma.-amino alcohols from .beta.-dicarbonyl compounds is disclosed. The dicarbonyls are reacted with alkoxyamines and the resultant alkoximino compounds reduced to yield .gamma.-amino alcohols. Also described are novel substituted .gamma.-amino alcohols.
    Type: Grant
    Filed: June 26, 1975
    Date of Patent: August 5, 1980
    Assignee: Philip Morris Incorporated
    Inventor: Henry V. Secor
  • Azetidine compounds and process for production
    Patent number: 4163855
    Abstract: Novel azetidine, and particularly 2-pyridyl-azetidine, compounds are disclosed. These compounds are produced from amino-esters by a sequence comprising conversion to the sulfonamide, reduction of the ester to the alcohol, sulfonation of the resultant alcohol and cylization to the N-sulfonylazetidine. This azetidine compound may then be transformed, as desired, to various N-derivatives by substitution of hydrogen or other univalent organic groups on the secondary amine of the azetidine ring.
    Type: Grant
    Filed: March 23, 1978
    Date of Patent: August 7, 1979
    Assignee: Philip Morris Incorporated
    Inventors: Henry V. Secor, William B. Edwards, III
  • Azetidine compounds and process for production
    Patent number: 4163856
    Abstract: Novel azetidine, and particularly 3-pyridyl-azetidine, compounds are disclosed. These compounds are produced from .gamma.-amino alcohols by a sequence comprising disulfonation to produce the sulfonamido-alkylsulfonate and then cyclization to the N-sulfonylazetidine. These azetidine compounds may then be transformed, as desired, to various N-derivatives by substitution of hydrogen or other univalent organic groups on the secondary amine of the azetidine ring.
    Type: Grant
    Filed: March 23, 1978
    Date of Patent: August 7, 1979
    Assignee: Philip Morris Incorporated
    Inventors: William B. Edwards, III, Henry V. Secor, Norman H. Cromwell
  • 2-Alkyl nicotinoids and processes for their production
    Patent number: 4155909
    Abstract: The invention relates to 2-alkyl nicotinoids and improved methods for producing them.
    Type: Grant
    Filed: June 13, 1977
    Date of Patent: May 22, 1979
    Assignee: Philip Morris Incorporated
    Inventors: Edward B. Sanders, Henry V. Secor, Jeffrey I. Seeman